Invesco China Health Care Equity Fd.C H/  LU2243645046  /

Fonds
NAV30.05.2024 Zm.-0,0100 Typ dystrybucji dochodów Kategoria Firma inwestycyjna
4,6700SGD -0,21% z reinwestycją Akcje Sector Health / Pharma Invesco Management 

Strategia inwestycyjna

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
 

Cel inwestycyjny

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
 

Dane podstawowe

Typ dystrybucji dochodów: z reinwestycją
Kategoria funduszy: Akcje
Kraj: Chiny
Branża: Sector Health / Pharma
Benchmark: MSCI China A Onshore Health Care Index
Początek roku obrachunkowego: 29.02
Last Distribution: -
Bank depozytariusz: -
Kraj pochodzenia funduszu: Luxemburg
Zezwolenie na dystrybucję: Austria, Niemcy, Szwajcaria
Zarządzający funduszem: Chris Liu, Kehong Jiang
Aktywa: 486,11 mln  EUR
Data startu: 15.12.2020
Koncentracja inwestycyjna: -

Warunki

Opłata za nabycie: 5,00%
Max. Administration Fee: 1,00%
Minimalna inwestycja: 1 200 000,00 SGD
Opłaty depozytowe: 0,01%
Opłata za odkupienie: 0,00%
Uproszczony prospekt: Ściągnij (Wersja do wydruku)
 

Firma inwestycyjna

TFI: Invesco Management
Adres: An der Welle 5, 60322, Frankfurt am Main
Kraj: Niemcy
Internet: www.de.invesco.com
 

Aktywa

Akcje
 
96,91%
Gotówka
 
3,09%

Kraje

Chiny
 
65,14%
Gotówka
 
3,09%
Kajmany
 
3,05%
Inne
 
28,72%

Branże

Farmacja/biotechnologia
 
50,29%
Medyczne produkty i instrumenty
 
14,53%
Usługi zdrowotne
 
3,36%
Pieniądze
 
3,09%
Inne
 
28,73%